Point of care Tuberculosis diagnostics using a novel diagnostic test without a need for electricity or laboratory facilities

Disgrifiad o Effaith

The newly developed test, based on proprietary lipid technology, will allow affordable testing for Tuberculosis at the point of care without a need for electricity or access to a specialist laboratory. Beneficiaries will be Tuberculosis patients (mainly in underdeveloped countries).

Buddiolwyr a cyrhaeddiad effaith ymchwil

Beneficiaries will be Tuberculosis patients (mainly in underdeveloped countries).

Statws effaith	Cyfredol
Categori effaith	Ansawdd Bywyd / Iechyd